Mark D. Roberson - Sep 1, 2022 Form 4 Insider Report for CYNERGISTEK, INC (CTEK)

Role
Director
Signature
/s/ Mark D. Roberson
Stock symbol
CTEK
Transactions as of
Sep 1, 2022
Transactions value $
$0
Form type
4
Date filed
9/1/2022, 02:05 PM
Previous filing
Nov 18, 2021
Next filing
Apr 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTEK Common Stock Award $0 +25K +35.21% $0.00 96K Sep 1, 2022 Direct F1
transaction CTEK Common Stock Disposed to Issuer -96K -100% 0 Sep 1, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTEK Stock Option (Right to Buy) Disposed to Issuer $0 -8.33K -100% $0.00* 0 Sep 1, 2022 Common Stock 8.33K $2.55 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Mark D. Roberson is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents accelerated vesting and settlement of restricted stock units (RSUs) pursuant to the Merger Agreement (as defined below).
F2 Disposed of pursuant to an Agreement and Plan of Merger, dated as of May 23, 2022 (the "Merger Agreement") by and among the Issuer, Clearwater Compliance LLC, a Tennessee limited liability company (the "Parent"), and Clearwater Compliance Acquisition Company I, a Delaware corporation and a wholly owned subsidiary of the Parent (the "Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. Each share of common stock exchanged in the Merger will receive cash of $1.25 per share.
F3 Pursuant to the terms of the Merger Agreement, this option, which fully vested on June 6, 2019, was canceled for no consideration at the effective time of the Merger because its exercise price exceeded the per share merger consideration of $1.25 per share.